Industry withdrawal from psychiatric medication development
Between 1950 and 1969, on a serendipitous basis, psychiatric drug development flourished. However, there has been a steep decline in the development of new medication classes. Instead of new molecular entities, slight molecular modifications producing “me-too” drugs attempted to garner market share....
| Published in: | Brazilian Journal of Psychiatry |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Associação Brasileira de Psiquiatria (ABP)
2014-09-01
|
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014000300259&lng=en&tlng=en |